Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $57.80 Consensus Price Target from Analysts
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month […]
